Instead , oral administration of S-1 ( a derivative of 5-FU ) , at 200 mg/day twice a week , was instituted , because S-1 has a strong inhibitory effect on dihydropyrimidine dehydrogenase , which catalyzes the degradative of 5-FU into FBAL .
O O O O O B-ChemicalEntity O O O O B-ChemicalEntity O O O O O O O O O O O O O B-ChemicalEntity O O O O O O B-ChemicalEntity O O O O O O O B-ChemicalEntity O B-ChemicalEntity O